Please login to the form below

Not currently logged in
Email:
Password:

PharmaLex appoints Zabin Younes as associate director

She joins from ERA Consulting

Development consulting and scientific affairs firm PharmaLex Group has expanded its regulatory team with the addition of Zabin Younes.

She joins the group as an associate director and arrives from ERA Consulting - a biopharmaceutical consultancy based in the UK - where she picked up experience in the biosimilar development lifecycle.

“We are aware that biosimilars continue to be a key area for many biopharmaceutical companies and are continuing to strengthen our team to ensure we remain a leading service provider and Zabin comes to us with a wealth of experience,” said Dr Thomas Dobmeyer, CEO of PharmaLex.

“Enhancing our service lines with experts who are at the top of their industry is a key attraction for our clients. It allows us to provide instant access to specialist knowledge helping clients to reduce timelines,” he added.

With experience spanning over 15 years, Younes’ expertise includes CMC regulatory strategies, monoclonal antibody biosimilars, developing and implementing global regulatory strategies, scientific advice and pre-submission activities.

In addition she also has over ten years of management experience and has set up and managed research teams, GMP testing laboratories and led MHRA/FDA corporate audits.

19th July 2017

From: Research

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
90TEN

90TEN is a global healthcare communications consultancy with a mission to make people healthier and happier through life-changing education and...

Latest intelligence

Emre Vural
Sourcing R&D innovation: why pharma companies need to evolve their business models
Recent years have seen a significant shift in drug development to specialty areas...
2020 - a year to remember or forget?
2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...
Gilead Headquarters
The search for effective drug treatments for COVID-19
PME talks to Julian Cole, Senior Director, Medical Affairs at Gilead Sciences...

Infographics